2017 Buyer’s Guide

This buyer’s guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

IRIS-MAIN Evaluates Differential Event Rates for Treatments of Unprotected Left Main CAD Patients

 

July 24, 2017—Findings from the Interventional Research Incorporation Society-Left Main Revascularization registry (IRIS-MAIN) were recently published online by Se Hun Kang, MD, et al in Circulation: Cardiovascular Interventions.

This large, international, multicenter registry evaluated differential event rates and independent predictors of long-term major cardiovascular events and death in 5,795 patients with unprotected left main coronary artery disease (CAD) who were treated with stents, bypass surgery, or medication. Identifying predictive factors for events in these patients is of great clinical value for risk stratification and possible guidance for tailored preventive strategies, advised the investigators.

The treatment strategies for patients in the registry were percutaneous coronary intervention (PCI) (n = 2,850), coronary artery bypass grafting (CABG) (n = 2,337), and medication alone (n = 608). The investigators analyzed the incidence and independent predictors of major adverse cardiac and cerebrovascular events (MACCEs), which was a composite of death, myocardial infarction, stroke, and repeat revascularization, as well as all-cause mortality in each treatment stratum.

As summarized in Circulation: Cardiovascular Interventions, during follow-up (median, 4.3 years), the rates of MACCEs and death were substantially higher in the medication group than in the PCI and CABG groups (P < .001).

In the PCI group, the three strongest predictors for MACCEs were chronic renal failure, age 65 years or older, and previous heart failure; those for all-cause mortality were chronic renal failure, older age, and low ejection fraction.

In the CABG group, age 65 years or older, chronic renal failure, and low ejection fraction were the three strongest predictors of MACCEs and death.

In the medication group, age 65 years or older, low ejection fraction, and diabetes mellitus were the three strongest predictors of MACCEs and death.

These findings demonstrated that among patients with unprotected left main CAD, the key clinical predictors for MACCEs and death were generally similar regardless of index treatment. This study provides effect estimates for clinically relevant predictors of long-term clinical outcomes in real-world left main CAD patients, providing possible guidance for tailored preventive strategies, concluded the investigators in Circulation: Cardiovascular Interventions.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.